Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study

다국어 초록 (Multilingual Abstract)

Objective: The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are markers that can determine the presence of systemic inflammatory response. In this study, we examined the NLR and PLR levels in patients with heroin dependence compared to healthy controls.
Methods: The study sample included 90 male patients with heroin dependence aged 18 to 45 years and 60 healthy subjects who had similar socio-demographic characteristics as the patient group. The diagnoses of heroin dependence and other Axis I psychiatric disorders in the patient and control groups were screened with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID-I). The extent of heroin addiction was assessed with the Addiction Severity Index (ASI).
Results: The mean NLR and PLR levels of patients with heroin dependence were significantly higher than the control subjects (p=0.031 and p＜0.001, respectively). Positive correlations were found between NLR, PLR and duration of the disorder.
Conclusion: Our results indicate that inflammatory processes may play a role in the pathophysiology of heroin dependence.

참고문헌 (Reference)

1 United Nations Office on Drugs and Crime, "World drug report 2010" United Nations Publications 2010

2 First MB, "User's guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version" American Psychiatric Press 1997

3 Na KS, "The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia" 48 : 277-286, 2014

4 Turkmen K, "The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients" 34 : 1229-1237, 2012

5 Balta S, "The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events" 26 : 680-681, 2015

6 Demircan F, "The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder" 5 : 27-33, 2016

7 Borissoff JI, "The hemostatic system as a modulator of atherosclerosis" 364 : 1746-1760, 2011

8 McLellan AT, "The fifth edition of the Addiction Severity Index" 9 : 199-213, 1992

9 Kuyumcu ME, "The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease" 34 : 69-74, 2012

10 Puppe B, "The effect of housing conditions and social environment immediately after weaning on the agonistic behaviour, neutrophil/lymphocyte ratio, and plasma glucose level in pigs" 48 : 157-164, 1997

11 Trevisi E, "Some physiological and biochemical methods for acute and chronic stress evaluation in dairy cows" 8 (8): 265-286, 2009

12 Zahorec R, "Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill" 102 : 5-14, 2001

13 Bhatti I, "Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophillymphocyte versus platelet-lymphocyte ratio" 200 : 197-203, 2010

14 Langer HF, "Platelet-vessel wall interactions in atheroscleroticdisease" 99 : 480-486, 2008

15 Gary T, "Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients" 8 : e67688-, 2013

16 Turkmen K, "Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients" 17 : 391-396, 2013

17 Shoji T, "Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis" 188 : 190-195, 2006

18 Koyama H, "Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans" 108 : 524-529, 2003

19 Pacifici R, "Pharmacokinetics and cytokine production in heroin and morphine-treated mice" 22 : 603-614, 2000

20 McCarthy L, "Opioids, opioid receptors, and the immune response" 62 : 111-123, 2001

21 Sacerdote P, "Opioids and the immune system" 20 (20): s9-s15, 2006

22 Vallejo R, "Opioid therapy and immunosuppression: a review" 11 : 354-365, 2004

23 Stefano GB, "Opioid and opiate immunoregulatory processes" 16 : 109-144, 1996

24 Demir S, "Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy" 11 : 2253-2258, 2015

25 Kalelioglu T, "Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder" 228 : 925-927, 2015

26 Sadock BJ, "Kaplan and Sadock's comprehensive textbook of psychiatry. 8th ed." Gunes Kitabevi 2007

27 Nelson CJ, "Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation" 14 : 170-184, 2000

28 Mehmet Akif Camkurt, "Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients" 대한정신약물학회 14 (14): 256-260, 2016

29 Chan YY, "Inflammatory response in heroin addicts undergoing methadone maintenance treatment" 226 : 230-234, 2015

30 Cakir U, "Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study" 27 : 180-184, 2015

31 Rimjhim Agrawal, "In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology" 대한정신약물학회 15 (15): 115-125, 2017

32 Wang Z, "Immune function alterations during 12 weeks of abstinence in heroin users" 61 : 241-246, 2015

33 Kim YK, "Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder" 104 : 91-95, 2007

34 Piepenbrink MS, "Humoral dysregulation associated with increased systemic inflammation among injection heroin users" 11 : e0158641-, 2016

35 Reece AS, "Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers" 4 : 6-, 2007

36 Mehmet Akif Camkurt, "Evaluation of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Fetal Cord Blood of Depressed Mothers" 대한정신약물학회 15 (15): 35-39, 2017

37 Merikangas KR, "Epidemiology of substance use disorders" 131 : 779-789, 2012

38 Semiz M, "Elevated neutrophil/lymphocyte ratio in patients with schizophrenia" 26 : 220-225, 2014

39 American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders"

40 Chen SL, "Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment" 7 : 1025-1033, 2012

41 Kwon HC, "Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer" 17 : 216-222, 2012

42 Nikolova M, "Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers" 4 (4): 908-910, 2002

43 Demirbas H, "Bagimlilik Siddetini Belirleme Olceginin Gecerlik-Guvenilirlilik calismasi" Ankara Universitesi Tip Fakultesi Psikiyatri Klinigi 2003

44 Fecho K, "Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats" 276 : 626-636, 1996

45 Ogel K, "Alkol ve Madde Kullanim bozukluklari: Tani, Tedavi ve Onleme" Yeniden Yayinlari 2010

46 Ozkurkcugil A, "Adaptation and reliability study of Structured Clinical Interview for DSM-IV Axis I disorders" 12 : 233-236, 1999

47 Brietzke E, "Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder" 23 : 1079-1082, 2009